GERN
Geron Corp
Price:  
1.32 
USD
Volume:  
7,560,939.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN Relative Valuation

-329.8%
Upside

As of 2025-07-13, the Relative Valuation of Geron Corp (GERN) is (3.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.32 USD, the upside of Geron Corp based on Relative Valuation is -329.8%.

The range of the Relative Valuation is (2.30) - (4.12) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 9.0x - 18.9x 13.6x
Forward P/E multiples 10.6x - 21.5x 14.2x
Fair Price (2.30) - (4.12) (3.03)
Upside -274.6% - -412.2% -329.8%
1.32 USD
Stock Price
(3.03) USD
Fair Price

GERN Relative Valuation - Historical P/E Data

Date P/E
2025-07-11 -6.05
2025-07-10 -6.32
2025-07-09 -6.60
2025-07-08 -6.37
2025-07-07 -6.28
2025-07-03 -6.55
2025-07-02 -6.41
2025-07-01 -6.32
2025-06-30 -6.46
2025-06-27 -6.83
2025-06-26 -7.01
2025-06-25 -6.96
2025-06-24 -7.10
2025-06-23 -6.51
2025-06-20 -6.92
2025-06-18 -7.10
2025-06-17 -6.64
2025-06-16 -7.10
2025-06-13 -6.92
2025-06-12 -7.15
2025-06-11 -7.06
2025-06-10 -7.33
2025-06-09 -7.42
2025-06-06 -7.33
2025-06-05 -7.15
2025-06-04 -7.06
2025-06-03 -7.19
2025-06-02 -6.55
2025-05-30 -6.96
2025-05-29 -6.78
2025-05-28 -6.64
2025-05-27 -6.83
2025-05-23 -6.64
2025-05-22 -6.78
2025-05-21 -6.14
2025-05-20 -6.37
2025-05-19 -6.37
2025-05-16 -5.82
2025-05-15 -5.54
2025-05-14 -5.45
2025-05-13 -5.50
2025-05-12 -5.86
2025-05-09 -5.41
2025-05-08 -5.77
2025-05-07 -6.00
2025-05-06 -6.05
2025-05-05 -6.51
2025-05-02 -6.32
2025-05-01 -6.55
2025-04-30 -6.46